Form 4 Tracker
Arcus Biosciences, Inc.
RCUS

9 insider filings · Latest: May 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 28, 2025Oct 28 11:02 PMRobert C. Goeltz II
Proposed Sale
5,000$20.00$100.0K

View →

Oct 28, 2025Oct 28 9:13 PMRobert C. Goeltz II
Proposed Sale
5,000$20.00$100.0K

View →

Oct 28, 2025Oct 28 9:09 PMJuan Jaen
Proposed Sale
100,000$19.88$2.0M

View →

Oct 6, 2025Oct 6 8:32 PMJennifer Jarrett
Proposed Sale
100,583$13.35$1.3M

View →

Sep 29, 2025Sep 29 8:36 PMALEXANDER AZOY
Proposed Sale
2,831$12.84$36.4K

View →

Sep 5, 2025Sep 5 8:24 PMALEXANDER AZOY
Proposed Sale
1,579$11.56$18.3K

View →

Dec 31, 2024Dec 31 9:10 PMGoeltz II Robert C.
Proposed Sale
3,594$15.00$53.9K

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 23, 2026Jan 27 1:21 AMRichard MarkusChief Medical Officer
Grant/Award
96,000$22.1396,000(D)

View →

Jan 23, 2026Jan 27 1:21 AMROSEN TERRY JDirector, Chief Executive Officer
Grant/Award
315,000$22.13315,000(D)

View →

Jan 23, 2026Jan 27 1:21 AMJaen Juan C.President
Grant/Award
126,000$22.13126,000(D)

View →

Jan 23, 2026Jan 27 1:21 AMCarolyn C. TangGeneral Counsel
Grant/Award
96,000$22.1396,000(D)

View →

Jan 23, 2026Jan 27 1:21 AMRobert C. Goeltz IIChief Financial Officer
Grant/Award
96,000$22.1396,000(D)

View →

Jan 23, 2026Jan 27 1:21 AMAlexander AzoyChief Accounting Officer
Grant/Award
14,050$22.1314,050(D)

View →

Jan 23, 2026Jan 27 1:21 AMJennifer JarrettChief Operating Officer
Grant/Award
126,000$22.13126,000(D)

View →